Cancer Family
Soft Tissue Neoplasm
CI-CAN-00000354Explore in graph →
Non-malignant442 active trials9 approved drugs183 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000354Explore in graph →
Clinical trials
2,079 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02086279 | AMH Levels Change During Treatment With GnRh Agonist | completed | N/A | 67 | University Magna GraeciaOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT00331643 | Ixabepilone in Treating Young Patients With Refractory Solid Tumors | completed | Phase 2 | 120 | National Cancer Institute (NCI)NIH | 1 | Nov 14, 2014 | clinicaltrials |
| NCT02283502 |
| Clinical Test of the MRgHIFU System on Uterine Fibroids(MRgHIFU) |
| unknown |
| Phase 1 |
| 20 |
| Chin-Jung WangOTHER |
| 1 |
| Nov 5, 2014 |
| clinicaltrials |
| NCT00834457 | A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe | completed | Phase 2 / Phase 3 | 49 | Parirenyatwa HospitalOTHER | 1 | Oct 30, 2014 | clinicaltrials |
| NCT00886873 | Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids(Mifemyo_2) | completed | Phase 2 / Phase 3 | 100 | Mediterranea Medica S. L.OTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT01281865 | Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00503295 | Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung | completed | Phase 2 | 53 | Oncolytics BiotechINDUSTRY | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01751919 | A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I) | completed | Phase 1 | 37 | Dong-A ST Co., Ltd.INDUSTRY | 1 | Oct 1, 2014 | clinicaltrials |
| NCT02246322 | A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.(EUS-FNA) | unknown | N/A | 144 | Istituto Clinico HumanitasOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT01786226 | Mifepristone to Treat Uterine Fibroids | terminated | Phase 2 / Phase 3 | 220 | Mediterranea Medica S. L.OTHER | 1 | Sep 5, 2014 | clinicaltrials |
| NCT00516295 | Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma | completed | Phase 2 | 7 | National Cancer Institute (NCI)NIH | 1 | Sep 2, 2014 | clinicaltrials |
| NCT01451424 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00958893 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | terminated | Phase 2 | 4 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 25, 2014 | clinicaltrials |
| NCT00683917 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 2 | 10 | Repros Therapeutics Inc.INDUSTRY | 2 | Aug 21, 2014 | clinicaltrials |
| NCT00702702 | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 56 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00735553 | Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 77 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00737282 | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids | terminated | Phase 3 | 175 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00785356 | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 8 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00853567 | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 71 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT01069120 | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 27 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00444379 | Anti-Retrovirals for Kaposi's Sarcoma(ARKS) | completed | Phase 4 | 224 | University of California, San FranciscoOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00237185 | A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene | completed | Phase 2 | 148 | Novartis PharmaceuticalsINDUSTRY | 3 | Aug 19, 2014 | clinicaltrials |
| NCT02061657 | Impact of Misoprostol on Blood Loss In Myomectomy Operations | completed | Phase 3 | 50 | Ain Shams UniversityOTHER | 1 | Aug 12, 2014 | clinicaltrials |
| NCT00003019 | Vinblastine and Methotrexate in Treating Children With Desmoid Tumors | completed | Phase 2 | 28 | Children's Oncology GroupNETWORK | 3 | Jul 25, 2014 | clinicaltrials |
| NCT00882258 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | completed | Phase 2 | 144 | Repros Therapeutics Inc.INDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00685828 | Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor | unknown | Phase 3 | 946 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Jul 4, 2014 | clinicaltrials |
| NCT00874029 | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids(Halt) | completed | N/A | 137 | Acessa Health, Inc.INDUSTRY | 3 | Jul 3, 2014 | clinicaltrials |
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | withdrawn | Phase 3 | 0 | Repros Therapeutics Inc.INDUSTRY | 2 | Jun 27, 2014 | clinicaltrials |
| NCT02103322 | Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions | completed | Phase 2 / Phase 3 | 48 | Amneal Pharmaceuticals, LLCINDUSTRY | 1 | Jun 27, 2014 | clinicaltrials |
| NCT01829022 | Multi-center Prospective Study on E-NOTES for Myomectomy With Traction of Multidirectional Sutures(E-NOTES) | completed | — | 35 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 26, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT02166554 | The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions(BAP) | completed | Phase 1 / Phase 2 | 216 | BioRegen Biomedical (Changzhou) Co., LtdINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT00245102 | Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | completed | Phase 2 | 147 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00937495 | Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | May 14, 2014 | clinicaltrials |
| NCT00521092 | Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | May 5, 2014 | clinicaltrials |
| NCT00330421 | Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT01381822 | Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors(TH-CR-410) | unknown | Phase 1 | 58 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 21, 2014 | clinicaltrials |
| NCT01816815 | Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 | completed | Phase 1 | 73 | BayerINDUSTRY | 3 | Apr 21, 2014 | clinicaltrials |
| NCT01631903 | Extension of Study ZPV-200 | completed | Phase 2 | 48 | Repros Therapeutics Inc.INDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01739621 | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 0 | Apr 16, 2014 | clinicaltrials |
| NCT01776892 | Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease | withdrawn | Phase 3 | 0 | University of AlbertaOTHER | 1 | Apr 8, 2014 | clinicaltrials |
| NCT02103933 | Pilot Study to Evaluate the Knowledge and Understanding on Surgery for Patients With Hysterectomy | unknown | — | 200 | National Cancer Center, KoreaOTHER_GOV | 0 | Apr 4, 2014 | clinicaltrials |
| NCT01491594 | Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | terminated | Phase 1 | 1 | Duke UniversityOTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00751036 | Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg(MACS0375) | terminated | Phase 3 | 94 | Novartis PharmaceuticalsINDUSTRY | 9 | Mar 26, 2014 | clinicaltrials |
| NCT01229436 | Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)(POINT X) | completed | Phase 3 | 254 | PfizerINDUSTRY | 8 | Mar 17, 2014 | clinicaltrials |
| NCT01421680 | The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients | completed | N/A | 144 | Seoul National University HospitalOTHER | 1 | Mar 14, 2014 | clinicaltrials |
| NCT00254267 | Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors | completed | Phase 2 | 35 | AmgenINDUSTRY | 0 | Feb 27, 2014 | clinicaltrials |
| NCT00367861 | Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance | completed | Phase 3 | 564 | Centre Leon BerardOTHER | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00399152 | Perifosine + Sunitinib Malate for Patients With Advanced Cancers | completed | Phase 1 | 15 | AEterna ZentarisINDUSTRY | 0 | Feb 19, 2014 | clinicaltrials |
| NCT00485355 | Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy | completed | N/A | 27 | The Cleveland ClinicOTHER | 1 | Feb 19, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Nov 25, 2014source: clinicaltrials